Long-term Debt and Lease Obligation of Amphastar Pharmaceuticals, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Long-term Debt and Lease Obligation in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Amphastar Pharmaceuticals, Inc. Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2025 was $608,749,000, a 1.2% increase year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

Amphastar Pharmaceuticals, Inc. Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $608,749,000 +$7,119,000 +1.2% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $608,582,000 +$12,136,000 +2% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $607,727,000 +$20,874,000 +3.6% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $603,858,000 +$9,852,000 +1.7% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $601,630,000 +$12,051,000 +2% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $596,446,000 -$41,760,000 -6.5% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $586,853,000 +$98,573,000 +20% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $594,006,000 +$521,134,000 +715% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $589,579,000 +$516,740,000 +709% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $638,206,000 +$564,195,000 +762% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $488,280,000 +$414,409,000 +561% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $72,872,000 -$1,476,000 -2% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $72,839,000 -$1,937,000 -2.6% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $74,011,000 -$1,541,000 -2% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $73,871,000 +$43,411,000 +143% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $74,348,000 +$42,014,000 +130% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $74,776,000 +$40,590,000 +119% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $75,552,000 +$42,649,000 +130% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $30,460,000 -$4,162,000 -12% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $32,334,000 -$4,076,000 -11% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $34,186,000 -$5,208,000 -13% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $32,903,000 -$5,176,000 -14% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $34,622,000 -$5,171,000 -13% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $36,410,000 +$5,437,000 +18% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $39,394,000 +$7,410,000 +23% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $38,079,000 +$5,473,000 +17% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $39,793,000 +$6,098,000 +18% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $30,973,000 -$8,733,000 -22% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $31,984,000 -$8,860,000 -22% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 $32,606,000 -$9,626,000 -23% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $33,695,000 -$6,412,000 -16% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $39,706,000 +$8,558,000 +27% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $40,844,000 +$8,488,000 +26% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 $42,232,000 +$8,069,000 +24% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $40,107,000 +$8,365,000 +26% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $31,148,000 +$2,056,000 +7.1% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $32,356,000 +$2,191,000 +7.3% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 $34,163,000 +$2,809,000 +9% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $31,742,000 -$3,056,000 -8.8% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $29,092,000 -$6,794,000 -19% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $30,165,000 -$5,941,000 -16% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $31,354,000 -$9,917,000 -24% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 $34,798,000 -$8,052,000 -19% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 $35,886,000 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 $36,106,000 +$26,037,000 +259% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 $41,271,000 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 $42,850,000 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q4 2013 $10,069,000 31 Dec 2013 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.